Nitrosamine Failure Report

Nitrosamines, including NDSRIs, can emerge during pharmaceutical manufacturing due to the reaction of secondary, tertiary, or quaternary amines in APIs with nitrosating agents, such as nitrite impurities. Understanding and mitigating this risk is crucial for patient safety and regulatory compliance.

Unpredictable N-Nitrosation

EMA guidelines highlight that not all amine-containing compounds undergo predictable nitrosation. If extensive efforts to synthesize an N-nitrosamine fail, it might indicate the impurity does not exist or poses no risk.

Orthogonal Forced Nitrosation Reactions

To evaluate the potential formation of novel N-nitrosamines, we conduct orthogonal forced nitrosation reactions. This comprehensive approach helps in exploring various risk factors for nitrosamine formation in pharmaceuticals, providing a thorough evaluation.

Chemical Insights and Risk Justification

Through our studies, we gain valuable chemical insights into the lack of N-nitrosamine formation, even with stoichiometric amounts of nitrosating agents. These insights support the absence of nitrosamine risk in drug substances and products, aiding in regulatory compliance.

Regulatory Submission Support

We prepare detailed failure reports to support regulatory submissions. Our documentation ensures thorough nitrosamine risk assessment and aligns with the requirements set by health authorities.

Why Conduct Feasibility Studies?

Early Detection: Identify potential nitrosamine sources early in the drug development process, preventing future contamination.
Regulatory Compliance: Ensure adherence to global guidelines from the FDA, EMA, and ICH M7.
Product Safety: Confirm the absence of harmful impurities to protect patient health.
Cost Efficiency: Avoid costly recalls and modifications by addressing nitrosamine risks early.

Veeprho’s Expertise

With research on over 850 nitrosamine-related impurities, Veeprho provides unparalleled expertise in conducting feasibility studies for NDSRI formation and preparing nitrosamine failure reports. Our advanced analytical techniques and predictive modeling ensure thorough risk assessment and effective mitigation strategies.

Ensuring Safety and Compliance

Our feasibility studies are designed to ensure that your pharmaceutical products are free from harmful nitrosamines. We offer early detection, actionable mitigation strategies, and ongoing regulatory compliance monitoring throughout the product lifecycle.

Cost Efficiency

By identifying and managing nitrosamine risks early in the drug development process, you can prevent expensive recalls, optimize resources, and ensure your products are market-ready without delays.

Contact Us: For more information or to request nitrosamine formation studies, contact our experts.

Contact Us

Synthesis Attempts and Failure Report Impurities

Catalog No.	Name of Impurity	CAS No.
VE0023116	(R)-2,3-dihydroxy-5-(1-hydroxy-2-(methylamino)ethyl)benzenesulfonic acid: Synthesis Attempts and Failure Report	N/A
VE0022650	1-Nitroso Cyano Guanidine: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0022647	2-Methyl-5-nitro-1-nitroso-1H-imidazole: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0023117	4,5-dihydroxy-2-(1-hydroxy-2-(methylamino)ethyl)benzenesulfonic acid: Synthesis Attempts and Failure Report	N/A
VE0022609	N-Nitroso Cangrelor: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0023118	N-Nitroso Brilliant Blue Impurity-1: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0022608	N-Nitroso Avanafil: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0022610	N-Nitroso Olanzapine: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0022604	N-Nitroso Pazopanib: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0020274	N-Nitroso Rifabutin: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0022611	N-Nitroso Staurosporine: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0023115	Prednisolone Phosphate Impurity E: Synthesis Attempts and Failure Report	N/A
VE0022607	N-Nitroso Azathioprine: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0023152	2-Nitroso Clonidine: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0023153	N-Nitroso Ticagrelor: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0023765	N-Nitroso Acetazolamide: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0023194	N-Nitroso Azelnidipine: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0023195	N-Nitroso Benidipine: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0023186	N-Nitroso Cilnidipine: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0023190	N-Nitroso Clevidipine: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0023192	N-Nitroso Isradipine: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0023189	N-Nitroso Lercanidipine: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0023114	N-Nitroso Nicardipine: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0023188	N-Nitroso Nifedipine: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0023187	N-Nitroso Nimodipine: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0023193	N-Nitroso Nisoldipine: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0023766	N-Nitroso Torsemide: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0023185	N-Nitroso-Felodipine: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0023184	N-Nitroso-Lacidipine: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0022645	1-nitroso-1-methylguanidine: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0022646	1-(4,6-diamino-1,3,5-triazin-2-yl)-1-nitrosoguanidine; Synthesis Attempts and Failure Report (Nap Test)	N/A
VE0023196	N-Nitroso Amlodipine: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0024544	N-Nitroso Manidipine: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0024545	N-Nitroso Nitrendipine: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0024546	N-Nitroso Nilvadipine: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0024611	N-Nitroso Metformin: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0024820	N-Nitroso Dexmedetomidine: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0024912	N-Nitroso-Desmethyl-Dalbavancin: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0024920	2-Methyl-1-nitroso-1H-imidazole: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0025851	Acetaminophen Impurity 7: Synthesis Attempts and Failure Report	3009-34-5
VE0025859	Bromfenac Acyl-β-D-Glucuronide: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0028251	Dexmedetomidine Oxide Impurity; Synthesis Attempts and Failure Report	N/A
VE0028218	Ethyl 1-nitroso-1H-tetrazole-5-carboxylate; Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0026949	N-Nitroso (3,4-dimethylphenyl) hydrazine; Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0028081	N-Nitroso 2-acetyl-2-decarbamoyldoxycycline; Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0028169	N-Nitroso Abemaciclib; Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0025793	N-Nitroso Adenine: Synthesis Attempts and Failure Report (NAP Test)	2615274-45-6
VE0026223	N-Nitroso Alectinib Impurity: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0026775	N-Nitroso Alprazolam Related Compound A: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0026430	N-Nitroso Amlodipine Impurity-1; Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027066	N-Nitroso Apremilast: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027438	N-Nitroso Axitinib: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0026331	N-Nitroso Brilliant Blue Impurity-3; Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0026411	N-Nitroso Carbidopa: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0028178	N-Nitroso Caspofungin (Ditrifluoroacetate Salt); Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0028177	N-Nitroso Caspofungin; Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0025795	N-Nitroso Chlorothiazide: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027137	N-Nitroso Chlorpromazine EP Impurity E: Synthesis Attempts and Failure Report (NAP Test)	2892260-30-7
VE0027873	N-Nitroso Darolutamide Amide Impurity: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027878	N-Nitroso Darolutamide Amine Impurity; Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027876	N-Nitroso Darolutamide Benzamide Impurity: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027879	N-Nitroso Darolutamide Impurity 1: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027870	N-Nitroso Darolutamide Pyrazole Benzonitrile Impurity: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027871	N-Nitroso Darolutamide: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027714	N-Nitroso Desmethyl Linagliptin: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027992	N-Nitroso Desmethyl Metacycline; Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027993	N-Nitroso Desmethyl Oxytetracycline; Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027434	N-Nitroso Desmethyl Ranitidine: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0026923	N-Nitroso Desmopressin: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027604	N-Nitroso Dolutegravir; Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0026950	N-Nitroso Eltrombopag Amino Impurity: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0026946	N-Nitroso Eltrombopag Impurity 1: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0026460	N-Nitroso Eltrombopag Impurity 3: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0026947	N-Nitroso Eltrombopag: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027376	N-Nitroso Encorafenib: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0025792	N-Nitroso Erlotinib: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027038	N-Nitroso Esomeprazole: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0025926	N-Nitroso Ezetimibe Azetidinone Ring Opened Impurity: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0025726	N-Nitroso Famotidine 1: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0026016	N-Nitroso Famotidine EP Impurity A: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0026017	N-Nitroso Famotidine-II: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0026140	N-Nitroso Finerenone: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0026394	N-Nitroso Fomepizole: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0028139	N-Nitroso Fosaprepitant; Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027610	N-Nitroso Glipizide: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027931	N-Nitroso Hydralazine; Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027825	N-Nitroso N-desmethyl Osimertinib: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027982	N-Nitroso N-Desmethyl Rifampicin; Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0025115	N-Nitroso N-Didesmethyl Tiotropium: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027801	N-Nitroso Neratinib: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027900	N-Nitroso Nilotinib; Synthesis Attempts and Failure Report (NAP Test)	2925306-68-7
VE0026392	N-Nitroso Nintedanib: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0028029	N-Nitroso Oxazepam; Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027872	N-Nitroso Palbociclib 2; Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027874	N-Nitroso Palbociclib Intermediate Stage I; Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027877	N-Nitroso Palbociclib Intermediate Stage II; Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027927	N-Nitroso Palbociclib Succinic Acid Adduct; Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027010	N-Nitroso Pantoprazole: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027521	N-Nitroso Paracetamol EP Impurity M: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0028263	N-Nitroso Rabeprazole; Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0026971	N-Nitroso Rilpivirine 2: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027779	N-Nitroso Rizatriptan; Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027661	N-Nitroso Ruxolitinib: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027446	N-Nitroso Sugammadex: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0028242	N-Nitroso Theophylline; Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0026346	N-Nitroso Tizanidine: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0025821	N-Nitroso Tofacitinib: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027355	N-nitroso-cis-carboline: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0028201	N-Nitroso-Desmethyl-Minocycline-2; Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027669	N-Nitroso-Hydroxychloroquine; Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027532	N-Nitroso-N-Desmethyl Rosuvastatin: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0027358	N-nitroso-trans-carboline: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0028217	Pranlukast Nitroso Impurity; Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0024821	Prucalopride DP-3 Impurity: Synthesis Attempts and Failure Report	1900715-94-7
VE0024822	Prucalopride DP-4 Impurity: Synthesis Attempts and Failure Report	1900715-95-8
VE0026186	Ribociclib Nitroso Impurity 3: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0028182	Vildagliptin Dehydro Diketo Impurity; Synthesis Attempts and Failure Report	N/A
VE0027837	(E)-4-(((E)-4-hydroxybut-2-enoyl)oxy)but-2-enoic acid: Synthesis Attempts and Failure Report	N/A
VE0028183	2-(((2,8-dimethoxy-1,3-dimethylbenzo[4′,5′]imidazo[2′,1′:2,3]imidazo[1,5-a]pyridin-12-yl)thio)methyl)-1-(5-methoxy-1H-benzo[d]imidazol-2-yl)-3,5-dimethylpyridin-4(1H)-one; Synthesis Attempts and Failure Report	N/A
VE0025725	3-(((2-((diaminomethylene)amino)thiazol-4-yl)methyl)thio)-N-nitroso-N-sulfamoylpropanimidamide: Synthesis Attempts and Failure Report (NAP Test)	N/A
VE0028102	3-[2-Hydroxy-1-(1-Methylethyl)-2-Nitrosohydrazino]-1-Propanamine; Synthesis Attempts and Failure Report (NAP Test)	146724-82-5
VE0027875	5-acetyl-1-nitroso-1H-pyrazole-3-carboxylic acid: Synthesis Attempts and Failure Report (NAP Test)	N/A

FAQ

Recent guidelines from regulatory bodies like the FDA and EMA focus on the identification, risk assessment, and control of nitrosamine impurities in pharmaceuticals. They require manufacturers to evaluate the potential sources and implement strategies to minimize or eliminate these impurities.

The acceptable intake of NDSRIs varies depending on the specific nitrosamine and regulatory guidelines. Generally, limits are set based on the potential carcinogenic risk, and manufacturers must ensure that levels in their products do not exceed these thresholds.

Preventing nitrosamine formation involves thorough risk assessment, controlling raw material quality, optimizing manufacturing processes, and avoiding the use of nitrosating agents. Regular monitoring and implementing robust mitigation strategies are crucial to minimizing the risk.

First name(Required)

Subject of contact(Required)

Email(Required)

Phone number(Required)

How can we help you?(Required)

Select country(Required)

Contact Us

Feel free to reach out to us with any questions or concerns.

Nitrosamine (NDSRI) Formation and Failure Report Services

Unpredictable N-Nitrosation

Orthogonal Forced Nitrosation Reactions

Chemical Insights and Risk Justification

Regulatory Submission Support

Why Conduct Feasibility Studies?

Our Services Include:

Veeprho’s Expertise

Ensuring Safety and Compliance

Cost Efficiency

Synthesis Attempts and Failure Report Impurities

FAQ

Contact Us

Nitrosamine (NDSRI) Formation and Failure Report Services

Unpredictable N-Nitrosation

Orthogonal Forced Nitrosation Reactions

Chemical Insights and Risk Justification

Regulatory Submission Support

Why Conduct Feasibility Studies?

Our Services Include:

Veeprho’s Expertise

Ensuring Safety and Compliance

Cost Efficiency

Synthesis Attempts and Failure Report Impurities

FAQ

What are the new guidelines for nitrosamines?

What is the acceptable intake of NDSRIs?

How to prevent nitrosamine formation?

Contact Us